A Multicentre Study Comparing the Efficacy of Rosuvastatin With Atorvastatin When Given for a Period of 16 Wks to Subjects With Coronary Heart Disease & a Previously Performed Percutaneous Coronary Intervention
Phase of Trial: Phase IV
Latest Information Update: 04 Aug 2016
At a glance
- Drugs Rosuvastatin (Primary) ; Atorvastatin; Clopidogrel; Simvastatin
- Indications Coronary disorders
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 18 Nov 2010 Actual end date (Mar 2006) added as reported by ClinicalTrials.gov.
- 20 Nov 2005 New trial record.